Skip to content
In Stock Dexilant
Acid Reflux

Dexilant

GERD develops when stomach contents move back into the oesophagus. Dexilant can be selected when acid suppression is needed beyond short-term relief. It reduces the amount of acid available to…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Dexlansoprazole
Select dosage:
Select pack Package Per unit Price
$ 6.47 $ 194.02
$ 4.21 $ 388.04 $ 252.76 Save 35%
$ 3.48 $ 582.06 $ 313.28 Save 46%
Free Regular Delivery $ 3.12 $ 776.08 $ 373.80 Save 52%
Best value Free Regular Delivery $ 2.74 $ 1,164.12 $ 493.06 Save 58%
$ 7.36 $ 220.72
$ 5.10 $ 441.44 $ 306.16 Save 31%
Free Regular Delivery $ 4.37 $ 662.16 $ 393.38 Save 41%
Free Regular Delivery $ 3.99 $ 882.88 $ 478.82 Save 46%
Best value Free Express Delivery $ 3.60 $ 1,324.32 $ 647.92 Save 51%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

GERD develops when stomach contents move back into the oesophagus. Dexilant can be selected when acid suppression is needed beyond short-term relief. It reduces the amount of acid available to irritate the oesophagus after reflux occurs.

Product information

Dexilant is a proton pump inhibitor medicine containing dexlansoprazole as its active ingredient. It is used when stronger or sustained suppression of stomach acid is needed for acid-related disorders such as GERD and erosive oesophagitis.

Ingredients

Dexlansoprazole belongs to the proton pump inhibitor class. The active substance is the R-enantiomer of lansoprazole.

Therapeutic indications

Clinical indications and therapeutic uses of Dexilant

GERD develops when stomach contents move back into the oesophagus. Repeated exposure to acid can cause heartburn, chest discomfort after meals, sour regurgitation, cough, or difficulty swallowing. Erosive oesophagitis is a more advanced form in which acid exposure has caused visible inflammation or injury to the oesophageal lining.

Dexilant can be selected when acid suppression is needed beyond short-term relief. It does not create an immediate barrier against reflux. Instead, it reduces the amount of acid available to irritate the oesophagus after reflux occurs.

Targeted symptom relief for acid-related disorders

Heartburn occurs when acidic stomach contents irritate the oesophageal lining. Difficulty swallowing may appear when inflammation causes tenderness, swelling, or narrowing. Reducing gastric acid gives damaged tissue a better environment for recovery, although symptom improvement and tissue healing may occur at different speeds.

Dexilant is not intended to treat every cause of chest pain or swallowing difficulty. New, severe, or unexplained chest pain needs urgent medical assessment, especially when accompanied by breathlessness, sweating, faintness, or pain spreading to the arm or jaw.

Directions for use

Capsule strengths and administration

Dexilant is supplied as hard gelatin modified-release capsules. The strengths associated with this product are selected according to the condition being treated, treatment phase, symptom response, age, and other medical factors.

The amount taken at each intake is set individually rather than being one fixed number for every person. A higher strength may be used for a defined healing course, while a lower strength may be selected for maintenance or symptom control. The prescriber determines the appropriate regimen.

Administration principles include:

  • Take the capsule by mouth.
  • Swallow it whole with water.
  • Follow the prescribed frequency.
  • Take it with or without food unless the prescriber specifies another routine.
  • Do not double the next intake after a missed dose.
  • If the next scheduled dose is close, skip the missed dose and resume the usual schedule.
  • Do not change the strength or duration without a prescriber’s instruction.

Food is not the same issue with Dexilant as it is with some other acid-suppression medicines. The dual delayed-release design permits administration without regard to meals, according to the FDA prescribing information.

If you miss a dose, avoid taking two doses together. A simple phone reminder linked to breakfast or another daily routine can prevent repeated missed doses without changing the prescribed timing.

The capsule should be stored in a dry place at ordinary room temperature, away from excessive heat and moisture. Bathroom storage can expose medicines to humidity that may affect capsules and modified-release granules.

Swallow the capsule at the same time each day unless the prescriber has given a different schedule. A regular routine makes missed doses less likely and helps keep acid suppression consistent.
Do not chew, crush, or grind Dexilant capsules. If swallowing the capsule is difficult, the prescribed product instructions may allow the capsule to be opened and the granules sprinkled on a small amount of soft food, without chewing the granules.

When not to use it

Contraindications and clinically important interactions

Dexilant is not suitable for people with a previous serious hypersensitivity reaction to dexlansoprazole, other proton pump inhibitors, or a relevant excipient. It should not be combined with rilpivirine-containing medicines because reduced gastric acidity can lower rilpivirine absorption.

The medicine requires extra caution in people with:

  • Previous severe reactions to acid-suppression medicines.
  • Liver impairment, especially when treatment involves the higher strength.
  • Low magnesium levels or a history of electrolyte disturbance.
  • Osteoporosis or a high risk of fragility fracture.
  • Previous C. difficile infection.
  • Suspected kidney inflammation.
  • Symptoms that could represent stomach or oesophageal cancer.

Dexilant may interact with medicines whose absorption depends on stomach acidity. It can also affect medicines processed through hepatic enzyme pathways. Tell the prescriber about anticoagulants, antiretroviral medicines, methotrexate, digoxin, tacrolimus, and other regular treatments before the regimen is selected.

Pregnancy and breastfeeding require an individual risk assessment. The Australian TGA and other regulators assess medicine use through product information and pharmacovigilance data; treatment decisions should account for the reason acid suppression is required and available alternatives.

When this is not for you

NOT for you if you have had a serious allergic reaction to dexlansoprazole, another proton pump inhibitor, or a relevant excipient.

Unwanted effects

Side effects and tolerability

Clinical trials and prescribing information associate Dexilant with headache, diarrhoea, abdominal pain, nausea, upper respiratory symptoms, and vomiting. Many reactions are mild, but persistent or severe symptoms need clinical review.

Longer courses of proton pump inhibitor treatment can be associated with changes in magnesium levels, vitamin B12 absorption, bone-fracture risk in susceptible people, intestinal infections, and kidney inflammation. These risks are more relevant when treatment is prolonged, when other risk factors exist, or when several medicines are taken together.

Seek prompt medical attention for:

  • Severe or persistent watery diarrhoea.
  • Black stools or vomiting blood.
  • Facial swelling, wheezing, or widespread rash.
  • Marked reduction in urine output.
  • Muscle cramps, tremor, palpitations, or seizures.
  • New difficulty swallowing or unintentional weight loss.

One practical detail is easy to miss: diarrhoea during acid-suppression treatment should not automatically be dismissed as a minor stomach upset. Persistent watery diarrhoea can signal Clostridioides difficile infection, which requires medical assessment.

Another detail concerns laboratory results. Prolonged proton pump inhibitor therapy may affect serum chromogranin A testing and can interfere with some investigations for neuroendocrine tumours. The treating clinician should know that Dexilant is being used before such testing.

Mechanism of action

Pharmacological mechanism of action

Dexlansoprazole belongs to the proton pump inhibitor class. It suppresses the final stage of acid production in gastric parietal cells by inhibiting the H+/K+-ATPase enzyme, often called the gastric proton pump. This reduces both basal acid secretion and acid secretion stimulated by meals or other signals.[1]

The active substance is the R-enantiomer of lansoprazole. After absorption, it reaches the acid-producing cells in the stomach and becomes active in the acidic canaliculi of those cells. It then binds to the proton pump through a covalent interaction, producing prolonged inhibition until new proton pumps are formed.

That mechanism explains why Dexilant can continue reducing acid after the medicine has left the bloodstream. The effect is pharmacodynamic rather than simply a direct coating effect on the oesophagus.

A proton pump inhibitor acts later in the acid-production pathway than medicines that block histamine signals. This helps explain its use for erosive oesophagitis and persistent GERD symptoms, where stronger acid suppression may be required.

Dual delayed-release formulation

Dexilant capsules contain two groups of modified-release granules. These granules release dexlansoprazole at separate points after administration, which creates two periods of medicine release rather than one single release event.

The first release occurs earlier in the digestive tract. The second occurs later, after the capsule has moved further through the gastrointestinal system. This design extends exposure to the active substance and helps maintain acid suppression across a longer part of the day.

Dual delayed release does not mean that every symptom disappears after the first dose. Healing of erosive oesophagitis can take longer than reduction in acid exposure, and persistent symptoms may require reassessment.

Common mistakes

Common patient mistakes

Several avoidable habits reduce the benefit of acid-suppression therapy:

  • Taking extra capsules because heartburn has not improved immediately.
  • Chewing or crushing modified-release granules.
  • Stopping after one comfortable day when the prescribed course is intended to heal erosive injury.
  • Continuing treatment indefinitely without a medication review.
  • Assuming every chest symptom is reflux.
  • Taking antacids, supplements, or herbal products without considering interactions.
  • Ignoring persistent diarrhoea, bleeding, or progressive swallowing difficulty.
  • Missing doses repeatedly and then judging the medicine ineffective.

A missed dose should not be compensated for with a double dose. A repeated pattern of missed doses is more useful information for the prescriber than an isolated late dose.

Night-time symptoms may also be worsened by lying down soon after a large meal. Elevating the head of the bed can help selected patients with nocturnal reflux, while stacking ordinary pillows may bend the body in a way that increases abdominal pressure instead.

Comparison

Comparison of acid-suppression approaches

Approach Main action Typical clinical role
Dexilant dual delayed-release PPI Suppresses the gastric proton pump through two release phases GERD, erosive oesophagitis, and longer acid control
Standard PPI formulation Suppresses the gastric proton pump through one main release phase Acid-related disorders requiring sustained suppression
H2-receptor blocker Reduces acid stimulation through histamine-receptor blockade Selected milder or intermittent acid symptoms

A proton pump inhibitor is usually chosen when sustained acid reduction is needed for healing or control of frequent reflux. H2-receptor blockers can have a faster perceived onset for some symptoms, yet their acid-suppression pattern and durability differ.

Dexilant’s dual delayed-release system is a formulation feature, not a separate drug class. Its clinical value depends on the diagnosis, the severity of acid injury, adherence, and whether symptoms are genuinely caused by reflux.

What doctors say

Doctor perspectives

In clinical practice, physicians usually assess whether symptoms fit reflux before extending acid-suppression treatment. Heartburn that responds to acid reduction supports the diagnosis, but it does not exclude other causes of chest or upper abdominal pain.

Doctors also look for alarm features. Progressive difficulty swallowing, bleeding, iron-deficiency anaemia, recurrent vomiting, unexplained weight loss, or symptoms beginning later in life may require investigation rather than repeated empirical treatment.

A common prescribing mistake is treating persistent symptoms as proof that a stronger capsule is needed. Ongoing symptoms can result from non-acid reflux, poor adherence, incorrect diagnosis, delayed gastric emptying, or another gastrointestinal condition.

The American Gastroenterological Association and National Institute for Health and Care Excellence materials support periodic review of prolonged proton pump inhibitor therapy, with treatment continued when there is a clear indication and adjusted when the clinical need changes.[2] This does not mean stopping suddenly without a plan. Rebound acid hypersecretion can cause temporary symptoms after discontinuation in some people.

What customers often ask

Can Dexilant be taken with food or on an empty stomach?

Dexilant can be taken with or without food because its dual delayed-release design is not dependent on a meal for activation. The 2022 FDA prescribing information supports administration without regard to food. Taking it at a consistent time can make adherence easier, even when the timing is not linked to breakfast. Large late meals may still worsen reflux symptoms despite correct medicine use.

How soon does Dexilant become noticeable?

Some people notice less heartburn within the first few days, while healing of erosive oesophagitis may take longer. Clinical response varies with the severity of inflammation, adherence, and the cause of symptoms. FDA-reviewed data from 2022 describe Dexilant as treatment for acid-related disorders rather than an instant rescue medicine. Symptoms that remain severe, worsen, or include swallowing difficulty require reassessment.

Does Dexilant affect driving, concentration, or work with machinery?

Dexilant is not generally classified as a sedative, but dizziness, headache, or visual symptoms can occur in some users. The Australian TGA's 2022 medicine information advises patients to respond individually to medicine effects, especially when beginning treatment or changing the regimen. Do not drive or operate machinery if dizziness, blurred vision, confusion, or unusual weakness develops. Alcohol can also impair alertness and worsen reflux symptoms in some people.

Which condition rules out Dexilant?

A previous serious allergic reaction to dexlansoprazole or another proton pump inhibitor rules out Dexilant. Concomitant use with rilpivirine-containing medicines is also contraindicated because reduced stomach acidity may lower rilpivirine exposure. Severe liver disease requires careful selection of the regimen rather than casual self-adjustment. The 2019 National Institute for Health and Care Excellence guidance describes medicine contraindications and interaction principles within its product-information framework.[3]

Which diet, exercise, or habits can help or hinder the result?

Large meals, lying down soon after eating, smoking, alcohol, and foods that personally trigger reflux can reduce symptom control. Smaller meals, remaining upright after eating, weight reduction when clinically appropriate, and regular physical activity may help. Exercise immediately after a large meal can provoke reflux in some people, while moderate activity at another time may support weight and digestive health. The WHO's 2020 guidance identifies tobacco control, healthy weight, and regular activity as major elements of long-term health behaviour.[4]

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Dexilant Current

Active ingredient: Dexlansoprazole
30mg 60mg
From $ 194.02
pills
4.4 (5)

Pariet

Active ingredient: Rabeprazole
20mg
From $ 165.54
pills
4.2 (5)

How the medicines for Acid Reflux compare

Sources

  1. U.S. Food and Drug Administration (2022). DEXILANT (dexlansoprazole) delayed-release capsules: Prescribing Information.
  2. American Gastroenterological Association (2022). Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
  3. National Institute for Health and Care Excellence (2019). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184).
  4. World Health Organization (2020). WHO guidelines on physical activity and sedentary behaviour.

How Buyers Rate Dexilant

Based on 5 reviews

Daniel, 54 Verified
Rating: 3.5 out of 5

He used Dexilant for reflux that had disturbed sleep for several months. Heartburn became less frequent during the first week, although he still avoided late meals because lying down soon after eating brought symptoms back.

Several months 5 Oct 2026
James P., 41 Verified
Rating: 5 out of 5

He reported better control after switching from irregular self-treatment to one consistent daily routine. He developed mild loose stools during the first fortnight, which settled without stopping treatment.

The first fortnight 13 Oct 2026
Simon F., 65 Verified
Rating: 5 out of 5

He took Dexilant during treatment for erosive oesophagitis and found swallowing less painful after several weeks. His clinician later reviewed his other medicines and reduced unnecessary long-term acid suppression.

Several weeks 16 Oct 2026
Luke, 40 Verified
Rating: 3.5 out of 5

He noticed improvement in burning symptoms but still had a persistent throat sensation. Further assessment suggested that reflux was not the only cause, so increasing the dose did not solve the problem.

27 Oct 2026
Jack, 66 Verified
Rating: 5 out of 5

He found the capsule convenient because it could be taken without coordinating it with meals. He missed several doses during travel and noticed that symptoms returned, so he used a daily reminder thereafter.

1 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 494 reviews Install